Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). | Cynosure Cynosure is a company that develops and manufactures aesthetic and medical treatment systems. | ||
Founding Date | Founding Date 1989 | Founding Date 2000 | Founding Date 1991 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Saint Paul, US HQ | Locations Mason, US HQ Amsterdam, NL Minnetonka, US Pleasanton, US | Locations Westford, US HQ Pymble, AU Hangzhou, CN Suzhou, CN Courbevoie, FR Langen (Hessen), DE Tokyo, JP see more |
Employees | Employees 7257% decrease | Employees 1,05020% increase | Employees 8221% increase |
Valuation ($) | Valuation ($) 844 m | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $236.2m (FY, 2022) | Revenue (est.) $399.2m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $63.4m (FY, 2022) | Cost of goods $98.9m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $172.8m (FY, 2022) | Gross profit $300.4m (FY, 2023) | Gross profit N/A |
Net income | Net income ($36.9m) (FY, 2022) | Net income ($30.4m) (FY, 2023) | Net income N/A |
Operating ⚠ | |||
Products | Products N/A | Products 6 (FY, 2022) | Products 20 (FY, 2016) |
Funding | |||
Total funding raised | Total funding raised $ 69m | Total funding raised $ 8.5m | Total funding raised N/A |